AXSOME THERAPEUTICS INCAXSOME THERAPEUTICS INCAXSOME THERAPEUTICS INC

AXSOME THERAPEUTICS INC

No trades
See on Supercharts

19X fundamentals

AXSOME THERAPEUTICS INC financial statements, including revenue, expenses, profit, and loss

The total revenue of 19X for the last quarter is 81.38 M EUR, and it's 17.08% higher compared to the previous quarter. The net income of Q2 24 is -74.08 M EUR.

Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth